Monte Rosa Therapeutics (GLUE) Other Operating Expenses (2022 - 2025)
Monte Rosa Therapeutics (GLUE) recorded quarterly Other Operating Expenses of $59000.0 in Q1 2025, up 145.83% quarter-over-quarter from $24000.0 in Q2 2023.
Monte Rosa Therapeutics (GLUE) Other Operating Expenses (2022 - 2025) Analysis & Trends
Monte Rosa Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $59000.0 for Q1 2025.
- In Q1 2025, Other Operating Expenses changed N/A year-over-year to $59000.0; the TTM figure through Dec 2025 stood at $59000.0 (changed N/A YoY), while the FY2025 annual figure was $59000.0, changed N/A from the prior year.
- Other Operating Expenses was $59000.0 for Q1 2025 at Monte Rosa Therapeutics, up from $24000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $125000.0 in Q1 2022 to a low of -$16000.0 in Q3 2022.
- Historically, Other Operating Expenses has averaged $48000.0 across 3 years, with a median of $41500.0 in 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Monte Rosa Therapeutics | 1.83 Bn | 1.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 59,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Sep 30, 2022 | -16,000.00 |
| Mar 31, 2022 | 125,000.00 |